We show that ABCG2 expression correlated with NMIBC recurrence and progression, and that ABCG2 expression is, in part, regulated by MAPK activity and this correlates with ours and published findings of activated ERK predicting poor prognosis in bladder cancer [44]. The gene discussed is ABCG2; the disease is urinary bladder cancer.